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Speciﬁcity protein 4
Transcription factorThe alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors are important glutamater-
gic receptors mediating fast excitatory synaptic transmission in the brain. The regulation of the four subunits
of AMPA receptors, GluA1-4, is poorly understood. Excitatory synaptic transmission is highly energy-
demanding, and this energy is derived mainly from the oxidative pathway. Recently, we found that speciﬁcity
factor regulates all subunits of cytochrome c oxidase (COX), a critical energy-generating enzyme. COX is also
regulated by nuclear respiratory factor 1 (NRF-1), which transcriptionally controls the Gria2 (GluA2) gene of
AMPA receptors. The goal of the present study was to test our hypothesis that Sp-factors (Sp1, Sp3, and/or
Sp4) also regulate AMPA subunit genes. If so, we wish to determine if Sp-factors and NRF-1 function via a com-
plementary, concurrent and parallel, or a combination of complementary and concurrent/parallelmechanism. By
means of multiple approaches, including electrophoretic mobility shift and supershift assays, chromatin immu-
noprecipitation, promoter mutations, real-time quantitative PCR, and western blot analysis, we found that Sp4,
but not Sp1 or Sp3, regulates the Gria2, but not Gria1, 3, or 4, subunit gene of the AMPA receptor in a concurrent
and parallel mannerwith NRF-1. Thus, Sp4 and NRF-1 bothmediate the tight coupling between neuronal activity
and energy metabolism at the transcriptional level.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Glutamate is the major excitatory neurotransmitter in the brain,
and the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptors are a major class of glutamatergic receptors (for re-
view see [1]). AMPA receptors are heterotetramers composed of various
combinations of the GluA1, GluA2, GluA3, and GluA4 subunits [2]. They
are widely expressed in the brain, where they mediate the majority of
ionotropic, ligand-gated, fast excitatory synaptic transmission [1]. As
such, AMPA receptors play crucial roles in normal neuronal activity,
including synaptic plasticity, synaptic scaling, homeostatic synaptic
plasticity, learning and memory, as well as in synaptogenesis and the
formation of neuronal circuitry [3–6]. Most AMPA receptors in the cere-
bral neocortex and hippocampus contain the GluA2 subunit, usually in
combination with the GluA1 subunit [7,8]. The GluA2 subunit is unique,
as its inclusion in the heterotetramer renders AMPA receptors signiﬁ-
cantly less permeable to Ca2+ [9]. In the adult, GluA3 expression is
much lower than those of GluA1 or GluA2 [7,10]. The GluA4 subunit is
present mainly during development [11].tor; Gria, gene name for AMPA
1 414 955 6517.Wehave shown previously that the expression of GluA2 is governed
by neuronal activity [12,13]. Excitatory glutamatergic neuronal activity
is highly energy-demanding, with most of this energy utilized to
extrude excess cations that enter through glutamatergic receptors (for
reviews see [14]). Thus, at the cellular level, an intimate link exists
between excitatory activity and the energy requirements of neurons.
Recently, we found that this link extends to the molecular level, in
that the same transcription factor, nuclear respiratory factor 1
(NRF-1), co-regulates genes that mediate energy metabolism and
neuronal activity. Speciﬁcally, NRF-1 regulates the expression of all
13 subunits of the energy-generating enzyme, cytochrome c oxidase
(COX), as well as the expression of the GluA2 subunit of the AMPA
receptor [15,16].
Speciﬁcity protein (Sp) is a family of zinc-ﬁnger transcription factors
that binds toGC-richDNAmotifs (for review see [17]). Sp1, Sp3, and Sp4
are three members of the Sp family that compete for the same cis-
motifs: the GC box ‘GGGCGG’ with high afﬁnity, or the GT (‘GGGTGG’)
and CT (‘CCCTCC’) boxes with signiﬁcantly lower afﬁnities [17,18].
While the expressions of Sp1 and Sp3 are ubiquitous, that of Sp4 is re-
stricted mainly to neurons and testicular cells [19]. Recently, we found
that, like NRF-1, Sp factors also regulate all 13 subunits of COX [20].
The question arises as to whether Sp factors also couple energy metab-
olism to neuronal activity by regulating speciﬁc subunits of the AMPA
receptor. If so, do they operate with NRF-1 via a complementary
Table 1
EMSA probes. Positions of probes are given relative to TSP. Putative Sp binding sites are
underlined.
Gene promoter Position EMSA sequence
Gria1 −189/−172 F: 5′ TTTTTGGAGAGGCAGGGGTGAT 3′
R: 5′ TTTTATCACCCCTGCCTCTCCA 3′
Gria2 −89/−64 F: 5′ TTTTGCGCTGTGCGGGGGAGGGGTGGGTGC 3′
R: 5′ TTTTGCACCCACCCCTCCCCCGCACAGCGC 3′
Gria3 −87/−69 F: 5′ TTTTCAATGAACCCGCCTTCCAG 3′
R: 5′ TTTTCTGGAAGGCGGGTTCATTG 3′
Gria4 +507/+527 F: 5′ TTTTGTAGCCCGGGCGGGGGTCGGC 3′
R: 5′ TTTTGCCGACCCCCGCCCGGGCTAC 3′
GM3 synthase −58/−38 F: 5′ TTTTGCGCGACCCCGCCCCCGCCTA 3′
R: 5′ TTTTTAGGCGGGGGCGGGGTCGCGC 3′
Mutant Sp Gria2 −89/−64 F: 5′ TTTTGCGCTGTGTTTTTTTTTTTTGTGTGC 3′
R: 5′ TTTTGCACACAAAAAAAAAAAACACAGCGC 3′
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the same subunit in the same direction), or a combination of comple-
mentary and concurrent/parallel mechanism? The goal of the present
study was to test our hypothesis that Sp1, Sp3, and Sp4 also mediate
the transcriptional coupling of synaptic transmission and energy
metabolism.
2. Material and methods
All experiments and animal procedures were performed in accor-
dance with the Guide for the Care and Use of Laboratory Animals
(National Institutes of Health Publications No. 80-23, revised 1996),
and all protocols were approved by the Medical College of Wisconsin
Animal Care and Use Committee (approval can be provided upon
request). All efforts were made to minimize the number of animals
used and their suffering.
2.1. Cell culture
The mouse neuroblastoma (N2a) cell line was acquired from ATCC
(Manassas, VA, USA) and grown in Dulbecco's modiﬁed Eagle's medium
supplemented with 10% fetal bovine serum, penicillin (50 units/mL),
and streptomycin (100 μg/mL) at 37 °C with 5% CO2.
Cultures of murine or rat primary visual cortical neurons were
carried out as described previously [21]. Brieﬂy, neonatal mouse or rat
pups (1-day-old) were killed by decapitation. Visual cortical tissue
was removed, trypsinized, and triturated. Individual neurons were
then plated in poly-L-lysine-coated, 35 mm dishes at a density of
200,000 cells/dish and maintained in Neurobasal-A media supple-
mented with B27. To suppress the proliferation of glial cells, Ara-C
(Sigma, St Louis, MO, USA) was added.
2.2. In silico analysis of promoters of murine AMPA receptor subunit genes
DNA sequences surrounding the transcription start points (TSPs)
of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptor subunit genes (Gria1–4) were derived from the NCBI mouse
genome database (Gria1 GenBank ID: NC_000077.6, Gria2 GenBank
ID: NC_000069.6, Gria3 GenBank ID: NC_000086.7, and Gria4 GenBank
ID: NC_000075.6). Computer-assisted search for the typical Sp1
binding motif (‘GGGCGG’), the atypical Sp1 binding motifs (‘GGGTGG’
and ‘CCCTCC’), or their complements, was conducted on sequences
encompassing 1 kb upstream and 1 kb downstream of the TSP of each
gene. These motifs were applicable to Sp1, Sp3, or Sp4.
To determine the degree of conservation of the Sp binding motif
among species, NCBI's Ensembl interface was used to align promoters
of AMPA receptor subunits from mice, rats, and humans.
2.3. Electrophoretic mobility shift and supershift assays
Todetermine if Sp1, Sp3, or Sp4 bound in vitro to putative Sp binding
elements in the promoter regions of AMPA receptor subunit genes, elec-
trophoretic mobility shift assays (EMSA) were carried out as described
previouslywith a fewmodiﬁcations [22]. Brieﬂy, oligonucleotide probes
containing putative Sp binding sequences on each AMPA receptor sub-
unit promoter (identiﬁed from in silico analysis), were synthesized
(Table 1), annealed, and labeled with [α-32P] dATP (50 μCi/200 ng;
Perkin-Elmer, Shelton, CT, USA) using Klenow fragment (Invitrogen).
Nuclear extract from mouse primary visual cortical tissue and HeLa
cells were isolated as described previously [23,24]. 10 μg of either
mouse cortical and/or HeLa nuclear extract was incubated with
2 μg of calf thymus DNA and with each labeled EMSA probe.
Supershift assays were performed with 1 μg of Sp4, 3, or 1 speciﬁc
antibody (Sp4, V-20, SC645; Sp3, H-225, SC13018; Sp1, H-225,
SC14027; all from Santa Cruz Biotechnology (SCBT), Santa Cruz, CA,
USA) and incubated with the probe/nuclear extract mixture for 20 min.The Sp4, Sp3, and Sp1 antibodieswere tested for speciﬁcity usingwestern
blot analysis and showed two adjacent bands at the appropriate molecu-
lar weights. These bands corresponded to the phosphorylated and
non-phosphorylated forms of Sp factors. For the cold competition exper-
iment, nuclear extracts were incubated with 100-fold excess of
unlabeled oligonucleotides. All reactions were loaded onto 4.5% poly-
acrylamide gel (58:1, Acrylamide:Bisacrylamide) and run for 3 h at
200 V in 0.25× Tris-borate-EDTA buffer. Results were visualized on a
phosphoimager and exposed on ﬁlm. The positive control probe, mu-
rine GM3 synthase gene, is known to bind Sp1 and contains two Sp1
binding sites in a tandem repeat [25]. The negative controls were
AMPA receptor subunit probes with mutated Sp binding sequences
(Table 1).
2.4. Chromatin immunoprecipitation (ChIP) assays
ChIP assays were performed on murine visual cortical tissue as de-
scribed previously [24]. Brieﬂy, murine visual cortical tissuewas quickly
removed, ﬁnely chopped, ﬁxed in 2% formaldehyde, and resuspended in
swelling buffer (85 mM KCl, 5 mM PIPES, pH 8.0, 1% Nonidet P-40, and
protease inhibitors). The tissuewashomogenized in aDounce tissueho-
mogenizer and centrifuged to isolate the nuclei. The nuclei were resus-
pended and sonicated in SDS lysis buffer (1% SDS, 50 mM Tris–HCl,
pH 8.1, 10 mM EDTA). Immunoprecipitation was performed with 2 μg
of Sp1, Sp3, or Sp4 antibodies. 2 μg of anti-nerve growth factor receptor
(NGFR) antibodies (sc-6188, SCBT) or ‘no antibody’ blanks was used as
negative controls. Semi-quantitative PCR, utilizing primers (Table 2)
surrounding the putative Sp binding sites identiﬁed through in silico
analysis, was performed. Positive controls for Sp factor binding were
GM3 synthase (known to bind Sp1) and neurotrophin 3 (known to
bind Sp4) [25,26]. β-actin promoter (Actb) was the negative control
(Table 2). PCR additives and cycling parameters used to improve the re-
producibility and quality of ChIP are listed in Table 2. 2% agarose gels
stained with ethidium bromide were used to visualize PCR products.
2.5. Construction of luciferase reporter vectors and transfection in N2a cells
The Gria2 luciferase reporter construct was created by PCR ampliﬁca-
tion of the mouse Gria2 proximal promoter (primers listed in Table 3).
The PCR product was digested with restriction enzymes (MluI and
BglII), and ligated into Promega's pGL3 luciferase vectors (E1751,
Promega,Madison,WI, USA). TheQuikChange site-directedmutagenesis
kit from Stratagene (La Jolla, CA, USA) was used to mutate putative Sp
binding sites. Primers used to create Sp mutations are listed in Table 3.
Sequencing was done to verify all constructs.
N2a cells, plated at 60% conﬂuency in 24-well plates, were transfected
with either 0.6 μg of the Gria2 reporter construct or 0.6 μg of the Gria2 re-
porter construct with mutated Sp binding site. pRL-TK (0.06 μg), a vector
with a thymidine kinase promoter that constitutively expresses renilla
luciferase, was added to each well and served as an internal control for
Table 2
Primers and conditions used for ChIP analysis.
Gene promoter Sequence Amplicon length Cycling conditions
Gria1 F: 5′ GGGAGGTGAAGGGGACAGTGGG 3′ 170 bp 94°: 30 s, 57°: 30 s, 72°: 45 s; 2.5% DMSO
R: 5′ CCCAGGAGCCAGCTCGGAGT 3′
Gria2 F: 5′ ATCGAATGCGCAAGACTGGA 3′ 201 bp 94°: 30 s, 60°: 30 s, 72°: 45 s; 2.5% DMSO
R: 5′ GAAAGTCACAGAGAGGGGCA 3′
Gria3 F: 5′ CAGAAATCGCTTTGGGGAACC 3′ 71 bp 94°: 30 s, 60°: 30 s, 72°: 45 s; 2.5% DMSO
R: 5′ ACTTCTGTCTTCACACCAATCTG 3′
Gria4 F: 5′ AGCCTCCCTGAAGACCTGGGC 3′ 231 bp 94°: 30 s, 60°: 30 s, 72°: 45 s; 2.5% DMSO
R: 5′ GGCTCCCTTGCGCTCCCTTG 3′
GM3 Synthase F: 5′ CACCTACTTCTCGGCTGGAG 3′ 198 bp 94°: 30 s, 57°: 30 s, 72°: 45 s.
R: 5′ AATTCAGCCCCGGACAGT 3′
NT3 F: 5′ GAGCAAACTCCAAAATGCCAGG 3′ 219 bp 94°: 30 s, 57°: 30 s, 72°: 45 s
R: 5′ AAAGTTGCGCCGGGCTATCTC 3′
β-Actin F: 5′ GCTCTTTTCCAGCCTTCCTT 3′ 187 bp 94°: 30 s, 57°: 30 s, 72°: 45 s
R: 5′ CGGATGTCAACGTCACACTT 3′
Table 4
Sp3 and Sp4 shRNA sequences. shRNA sequences cloned into the pLKO.1 vector for
silencing of Sp3 and Sp4.
Gene Hairpin sequence
Sp3 1 5′ CCGG-ATGAGAAACTGTTGGTATTTA-CTCGAG-TAAATACCAACAGTTT
CTCAT-TTTTTG 3′
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formed for 5 h as described previously [27]. Cells were harvested 48 h
after transfection and the lysates were measured for luciferase activity.
The average from six independent transfections for each promoter con-
struct is reported.
2.6. Plasmid construction of Sp1, Sp3, and Sp4 shRNA, transfection,
and KCl treatment
Sp1 silencing was carried out using a combination of three to ﬁve
Sp1-speciﬁc hairpin RNA (shRNA) (sc-29488, SCBT). Speciﬁc shRNA
sequences for silencing murine Sp3 or Sp4 were chosen from the
RNAi Consortium's Public TRC Cloning Database at the Broad Institute
(Table 4). The sequences were cloned into Addgene's pLKO.1 TRC clon-
ing vector (Plasmid 10878, Addgene, Cambridge, MA, USA). The pLKO.1
non-mammalian shRNA control vector (SHC002, Sigma), which con-
tains a scrambled shRNA sequence that targets no known mammalian
genes, was used as the control.
N2a cells at 60% conﬂuence in 6-well disheswere transfected theday
after plating with either the pLKO.1 non-mammalian control vector
(3 μg), or the Sp1, Sp3, or Sp4 shRNA vector constructs (3 μg). TurboGFP
(1 μg) vector was added to all wells to monitor transfection and selec-
tion efﬁciency. Transfectionwas performed using 5 μL of JetPrime trans-
fection reagent (PolyPlus Transfection, Illkirch, France) per well. To
select for purely transfected cells, 5 μg/mL of puromycin was added
1.5 days after transfection. Transfection efﬁciency was around 75% but
the addition of puromycin effectively yielded 100% transfected
cells. KCl stimulation was performed at a ﬁnal concentration of
20 mM for 5 h as previously described [27].
Transfection of murine or rat primary neuronal cultures was carried
out 5 days post-plating with Sp1, Sp3, or Sp4 shRNA constructs (2 μg) or
the pLKO.1 non-mammalian control (2 μg) using Neurofect transfection
reagent per 6-well plate according to the manufacturer's instructions
(Genlantis, San Diego, CA). TurboGFP (0.5 μg) vector was added to
each well for transfection visualization and selection efﬁciency. Trans-
fection efﬁciencywas around 40–50% before selection. Puromycin selec-
tion, however, effectively yielded 100% transfected cells. KCl stimulationTable 3
Primers used for promoter cloning andmutagenesis analysis. Mutated Sp binding sites are
underlined.
Gene
promoter
Position Primer
Gria2 −947/+152 F: 5′ CAGACGCGTCCCAAGCAGGCTCGGTGTAATGA 3′
R: 5′ CAGAGATCTGCTGTGGTCCCGGTGTCTGG 3′
Mutant Sp
Gria2
−90/−52 F: 5′ GGCGCTGTGCGTGTGAGTGTTGTGTGCGCGAGCTCGC
CG 3′
R: 5′ CGGCGAGCTCGCGCACACAACACTCACACGCACAGCG
CC 3′was performed on rat visual cortical neurons as described for N2a cells
above.
2.7. Sp1, Sp3, and Sp4 over-expression and TTX treatment
cDNA clones for human Sp1, Sp3, and Sp4 (OpenBiosystems, Lafayette,
CO, USA) were cloned into pcDNA Dest40 vectors (Gateway Multisite
Cloning kit, Invitrogen) according to the manufacturer's instructions
and as described previously [20].
Transfection procedure for N2a cells and primary neuronal culture
was similar to that described above. Either 1.5 μg of Sp1, Sp3, or Sp4
over-expression vector, or 1 μg of the pcDNA3.1 empty vector and
0.5 μg of turboGFP vector was used for both N2a cells and primary neu-
ronal cultures. Three days of TTX treatment (0.4 μM) commenced the
day after plating as previously described [27]. Primary neuronal cultures
and N2a cells with TTXwere harvested 4 days after transfection,where-
as those without TTX were harvested 2 days after transfection.
2.8. RNA isolation and cDNA synthesis
TRIZOL (Invitrogen) was used to isolate total RNA according to the
manufacturer's instructions. DNase I treatment was done on 1 μg of
total RNA, and cDNA was synthesized with iScript cDNA synthesis kit
(170-8891, BioRad, Hercules, CA, USA).
2.9. Real-time quantitative PCR
The Cepheid Smart Cycler Detection system (Cepheid, Sunnyvale,
CA, USA) and/or the iCycler System (BioRad) were used with the IQ
SYBR Green SuperMix (170-8880, BioRad) to perform real-time5′ AATTCAAAAA-ATGAGAAACTGTTGGTATTTA-CTCGAG-TAAATACCAA
CAGTTTCTCAT 3′
2 5′ CCGG-TTACCTTTGTACCAATCAATA-CTCGAG-TATTGATTGGTACAAA
GGTAA-TTTTTG 3′
5′ AATTCAAAAA-TTACCTTTGTACCAATCAATA-CTCGAG-TATTGATTGG
TACAAAGGTAA 3′
Sp4 1 5′ CCGG-CCAGTAACAATCACTAGTGTT-CTCGAG-AACACTAGTGATTGTT
ACTGG-TTTTTG 3′
5′ AATTCAAAAA-CCAGTAACAATCACTAGTGTT-CTCGAG-AACACTAGTG
ATTGTTACTGG 3′
2 5′ CCGG-CTGGACAACAGCAGATTATTA-CTCGAG-TAATAATCTGCTGTTG
TCCAG-TTTTTG 3′
5′ AATTCAAAAA-CTGGACAACAGCAGATTATTA-CTCGAG-TAATAATCTG
CTGTTGTCCAG 3′
Table 5
Real-time qPCR primers.
Gene Primer
Gria1 F: 5′ GAGCAACGAAAGCCCTGTGA 3′
R: 5′ CCCTTGGGTGTCGCAATG 3′
Gria2 F: 5′ AAAGAATACCCTGGAGCACAC 3′
R: 5′ CCAAACAATCTCCTGCATTTCC 3′
Gria3 F: 5′ TTCGGAAGTCCAAGGGAAAGT 3′
R: 5′ CACGGCTTTCTCTGCTCAATG 3′
Gria4 F: 5′ GGCTCGTGTCCGCAAGTC 3′
R: 5′ TTCGCTGCTCAATGTATTCATTC 3′
Sp1 F: 5′ CTCCAGACCATTAACCTCAGTG 3′
R: 5′ ATCATGTATTCCATCACCACCAG 3′
Sp3 F: 5′ TCAGGCACAGACAGTGACCCCT 3′
R: 5′ AGCGTGAGTGTCTGAACAGGCG 3′
Sp4 F: 5′ TTGCAGCAAGGCCAGCAGACC 3′
R: 5′ GCTTCTTCTTTCCTGGTTCACTGCT 3′
Actb F: 5′ GTGACGTTGACATCCGTAAAGA 3′
R: 5′ GCCGGACTCATCGTACTCC 3′
Gapdh F: 5′ AGGTCGGTGTGAACGGATTTG 3′
R: 5′ GGGGTCGTTGATGGCAACA 3′
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ysis are listed in Table 5. Primer sequences were the same for mouse
and rat. RTqPCR conditions were optimized to yield an ampliﬁcation
efﬁciency of 95%–105%. Products were run on agarose gel to verify
the correct ampliﬁcation length. Melt curve analyses of each PCR re-
action was performed to verify the formation of a single desired PCR
product. The 2−ΔΔCT method was used to quantify the relative
amount of transcripts, with β-actin and Gapdh acting as the internal
controls for N2a cells and primary neurons, respectively.
2.10. Western blot analysis
Sample buffer (12.5 mM EDTA, 50mM Tris–HCl pH 6.8, 1% SDS, 10%
glycerol) was used to harvest control, shRNA, and over-expression
protein samples. Equal protein amounts of each sample were loaded
onto 10% SDS-PAGE gel and electrophoretically transferred onto
polyvinylidene diﬂuoride membranes. Membranes were blocked with
5% non-fat dry milk and incubated in primary antibodies against Sp1
(1:1000; Santa Cruz), Sp3 (1:1000; Santa Cruz), Sp4 (1:1000; Santa
Cruz), GluA1 (1:500; Ab1504, Millipore Chemicon, Billerica, MA, USA),
GluA2 (1:200; 75-002 clone L21/32, UC Davis/NIH NeuroMab Facility,
Davis, CA, USA), GluA3 (1:50; sc-7613, Santa Cruz) and GluA4 (1:50;
sc-7614, Santa Cruz). The loading control was β-actin (1:5000; Sigma).
Secondary antibodies were from Vector Laboratories (Burlingame, CA,
USA) and ECL reagent was used to visualize protein position and intensi-
ty. Gel Doc from BioRad (Hercules, CA, USA)was used to perform quanti-
tative analyses of relative changes.
2.11. Statistical analysis
Analysis of variance (ANOVA)was applied to determine signiﬁcance
amonggroupmeans. The Student's t-testwas then applied to determine
signiﬁcance between two groups. P-values of 0.05 or less were consid-
ered signiﬁcant.
3. Results
3.1. In silico promoter analysis of AMPA receptor subunit genes
Computer assisted search for the typical Sp binding motif, the
GC\box (GGGCGG), in the DNA sequence 1 kb upstream and 1 kb
downstream of the transcription start site (TSP) of the AMPA receptor
subunit genes revealed the motif on the Gria3 and Gria4, but not the
Gria1 or Gria2 promoter region. The Gria2 promoter contained the
atypical Sp binding motif, the GT-box (GGGTGG). The Gria1 promotercontained GC rich regions, in which sequences resembling the Sp bind-
ing motif were present (see Table 1 for binding motifs).
3.2. In vitro binding of Sp proteins to AMPA receptor subunit promoters
The ability of Sp1, Sp3, and Sp4 to bind candidate sites in vitro was
determined by electrophoretic mobility shift (EMSA) and supershift as-
says. The positive control for Sp bindingwas theGM3 synthasepromoter
[25], which contained two Sp1 binding sites (2 GC-boxes) in tandem.
When incubated with HeLa nuclear extract, GM3 synthase formed
speciﬁc DNA/Sp1, DNA/Sp3, and DNA/Sp4 shift and super shift com-
plexes (Fig. 1, lane 6 for Sp1/Sp3/Sp4 shift, lanes 8, 9, and 10 for Sp1,
Sp3, and Sp4 supershifts, respectively). As Sp1 is capable of homotypic
interactions that lead to multimeric complexes [17], the Sp1 supershift
reaction may be detecting two Sp1 proteins bound to the tandem
GC-boxes (Fig. 1, lane 8, Sp1 Supershift*). When incubated with
mouse visual cortical tissue nuclear extract, GM3 synthase formed spe-
ciﬁc DNA/Sp3 and DNA/Sp4 shift and supershift complexes (Fig. 1,
lane 1 for Sp3/Sp4 shift, lanes 4 and 5 for Sp3 and Sp4 supershift, respec-
tively) but did not form a DNA/Sp1 shift or supershift complex (Fig. 1,
lanes 1 and 3 respectively). The lack of a strong Sp4 supershift with
HeLa nuclear extract as compared to mouse visual cortical nuclear ex-
tract is consistent with our previous observations of different levels of
Sp4 abundance in the two nuclear extracts andwith its reported neuro-
nal distribution [19,28]. Similarly, the lack of Sp1 shift or supershift with
mouse cortical nuclear extract as compared to HeLa nuclear extract was
due to the lower abundance of Sp1 in mouse cortical nuclear extract as
compared toHeLa nuclear extract [28]. The shift bands for visual cortical
and HeLa nuclear extract were competed out with the addition of cold
competitors (Fig. 1, lanes 2 and 7, respectively).
When mouse visual cortical nuclear extract was incubated with
AMPA receptor subunit probes containing putative Sp sites, Gria2 gave
positive shift and supershift bands against Sp factors. Speciﬁcally, a
shift band was observed (Fig. 1, lane 11) that was competed out with
the addition of unlabeled competitors (Fig. 1, lane 12). A supershift
band against Sp4 was present (Fig. 1, lane 15) but there were no
supershift bands against Sp1 or Sp3 (Fig. 1, lanes 13 and 14, respectively).
The addition of unlabeled probe with mutated Sp binding site did not
compete out the Sp4 shift band (Fig. 1, lane 16) and shift reactions with
mutated Sp site did not reveal Sp binding (Fig. 1, lane 17). Gria1, Gria3,
and Gria4 did not give positive shift (Fig. 1, lanes 18, 20, and 22, respec-
tively) nor Sp4 supershift bands (Fig. 1, lanes 19, 21, and23, respectively).
3.3. In vivo interaction of Sp factors with AMPA receptor subunit genes in
murine visual cortex
Interactions of Sp factors with AMPA receptor subunit gene pro-
moters were veriﬁed in vivo by chromatin immunoprecipitation
(ChIP) assays of mouse visual cortical nuclear extract. As seen in Fig. 2,
PCR products from all 0.5% and 0.1% input DNA reactions revealed
speciﬁc bands. There were enriched bands for GM3 synthase and
neurotrophin 3 positive controls in the Sp4 immunoprecipitated sam-
ples. An enriched band was present for Gria2, but not for the β-actin
negative control nor for the Gria1, Gria3, and Gria4 promoters. No
enrichment was found for samples immunoprecipitated with NGFR nor
in the “no antibody” negative controls. There was also no enrichment of
DNA in the Sp1 or Sp3 immunoprecipitated samples for any of the tested
regions (data not shown).
3.4. Effect of mutated Sp binding site on Gria2 promoter
The wild type Gria2 promoter as well as the Gria2 promoter with
mutated Sp binding site were transfected separately into N2a cells.
Analysis revealed a signiﬁcant 56% decrease in the activity of Gria2 pro-
moter containing the mutated Sp motif as compared to the wild type
control (P b 0.001, Fig. 3).
Fig. 1. In vitro binding of Sp factors to theGM3 synthase andGria2 promoters using EMSA and supershift assays. All lanes contain 32P-labeled oligonucleotides and are labeled by a “+” or a
“−” sign depending onwhether they also containmouse visual cortical orHeLa nuclear extract, excess oligos ormutant oligos (unlabeled), and Sp1, Sp3, or Sp4 antibodies. Sp1, Sp3, or Sp4
shift, supershift, and non-speciﬁc complexes are indicated by arrows. The positive control for Sp factor binding was GM3 synthase. Speciﬁc Sp1, 3, or 4 shift bands were revealed upon
incubationwith cortical (lanes 1–5) or HeLa (lanes 5–10) nuclear extract (lanes 1 and 6, respectively). Excess unlabeled competitor competed the shift bands (lanes 2 and 7). The addition
of Sp1 antibody did not yield a supershift bandwith cortical nuclear extract (lane 3) but gave two speciﬁc supershift bands with HeLa nuclear extract (lane 8), corresponding to the pres-
ence of tandem Sp binding. The addition of Sp3 antibody yielded a faint speciﬁc supershift band with cortical nuclear extract (lane 4) and a stronger supershift band with HeLa nuclear
extract (lane 9). The addition of Sp4 antibody yielded a very strong supershift band with cortical nuclear extract (lane 5) and a much fainter supershift band with HeLa nuclear extract
(lane 10). The relative levels of the Sp1, Sp3, and Sp4 supershift bands in mouse cortical and HeLa nuclear extract corresponds to the relative levels of these transcription factors in
these tissue and cell types. As Sp1, 3, and 4 all recognize the same cismotif, their combined binding yielded a rather thick shift band. However, with shorter gel exposure (boxed lanes
1 to 10 highlighted in the lower left), the individual shift bands can sometimes be dissociated. As shown in lane 1 in the inset, cortical nuclear extract did not reveal any detectable Sp1
shift band, but did show distinct Sp3 and Sp4 bands. The Sp3 shift band disappearedwhen it was supershifted (lane 4). Likewise, the Sp4 shift band disappearedwhen it was supershifted
(lane 5). With HeLa nuclear extract, the rather abundant presence of both Sp1 and Sp3 caused the bands to merge evenwith lighter exposure (lane 6). However, the upper portion (Sp1)
disappeared when supershifted with Sp1 antibody (lane 8), and the lower portion (Sp3) became lighter when supershifted with Sp3 antibody (lane 9). No change was detectable with
anti-Sp4 antibody (lane 10), indicating that HeLa nuclear extract did not contain detectable Sp4. Incubation of cortical nuclear extract with the Gria2 probe yielded a speciﬁc Sp4 shift
band (lane 11) which was competed out with the addition of excess cold probes (lane 12). The addition of Sp4 antibody yielded a speciﬁc supershift band (lane 15), but the addition
of Sp1 and Sp3 antibodies did not (lanes 13 and 14). The addition of excess unlabeled mutant Gria2 probes did not compete out the shift reaction (lane 16). Labeled Gria2 probes with
mutant Sp sites did not yield speciﬁc Sp shift bands (lane 17). Labeled Gria1, Gria3, and Gria4 probes did not yield speciﬁc Sp shift (lanes 18, 20, and 22, respectively) or Sp4 supershift
bands (lanes 19, 21, and 23, respectively).
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to KCl stimulation
Wehave shown previously that the KCl-mediated increase in neuro-
nal activity up-regulates the Gria2 promoter. To determine if Sp factorFig. 2. Sp4 interactionswith AMPA receptor subunit promoters inmouse visual cortical tissue. P
with anti Sp4 antibodies (Sp4 IP lane), anti-nerve growth factor receptor p75 antibody (negativ
lane) and 0.1% (input 0.1% IP lane) of input chromatin served as control reactions for PCR. Positiv
negative control. Sp4 interacted with Gria2, but not with Gria1, Gria3, or Gria4.binding is necessary for this activity-mediated up-regulation, Gria2 con-
trol promoters or Gria2 promoters withmutated Sp site were transfected
into N2a cells and subjected to depolarizing KCl (20 mM) treatment. As
shown in Fig. 3, N2a cells transfected with the control Gria2 promoter
and subjected to KCl stimulation showed a 47% increase in promoterrecipitation of chromatinwas carried out frommouse visual cortical tissue nuclear extract
e control, NGFR IP lane), or no antibody (negative control, No Ab lane). 0.5% (input 0.5% IP
e controls for Sp4 bindingwereGM3 synthase andNeurotrophin 3, whereasβ-Actinwas the
Fig. 3. Relative luciferase activity of the wild type Gria2 promoter (wt) and the Gria2 pro-
moter with mutated Sp binding site (mut). Mutating the Sp binding site on Gria2 resulted
in a signiﬁcant decrease in luciferase activity as compared to the wild type promoter. KCl
depolarization signiﬁcantly increased Gria2 wild type promoter activity, but could not
increase activity in the Gria2 promoter with mutated Sp site. N = 6 for each construct.
*** = P b 0.001; X = NS. Both mutant and wild type + KCl were compared to the wild
type. The mutant + KCl was compared to the mutant.
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ing site (Fig. 3), conﬁrming a requirement for Sp binding in the activity-
induced up-regulation of the Gria2 promoter.
3.6. Effect of silencing Sp1, Sp3, and Sp4 by RNA interference on AMPA
receptor subunits in N2a cells
To determinewhether a knockdown of Sp1, Sp3, or Sp4 had an effect
on the expression of AMPA receptor subunits, respective Sp proteins
were silenced in N2a cells by means of 2–5 speciﬁc plasmid shRNA
vectors. Quantitative real-time PCR indicated that silencing Sp4
decreased Sp4 mRNA levels by 68% (P b 0.001, Fig. 4A) and Sp4 pro-
tein levels by 56% (P b 0.01, Fig. 4C–D). Sp4 silencing also decreased
Gria2 mRNA levels by 62% (P b 0.001; Fig. 4B) and protein levels by
41% (P b 0.05, Fig. 4E–F).mRNA levels ofGria1,Gria3, andGria4, howev-
er, did not change signiﬁcantly with Sp4 silencing (Fig. 4B), nor did the
protein level of GluA1 (Fig. 4E–F), GluA3 or GluA4 (Supplementary
Fig. 1A–B).
Silencing of Sp1 resulted in a 71% decrease in its mRNA levels
(P b 0.001, Fig. 4A) and a 63% decrease in its protein levels (P b 0.01,
Fig. 4C–D). Silencing of Sp3 resulted in a 66% decrease in itsmRNA levels
(P b 0.001, Fig. 4A) and a 52% decrease in its protein levels (P b 0.01,
Fig. 4C–D). However, mRNA levels of Gria1, Gria3, and Gria4 (Fig. 4B),
or protein levels of GluA1 and GluA2 (Fig. 4E–F), GluA3 and GluA4
(Supplementary Fig. 1A–B) were not changed signiﬁcantly with Sp1
or Sp3 silencing.
3.7. Effect of silencing Sp1, Sp3, and Sp4 by RNA interference on AMPA
receptor subunits in primary neurons
To determine whether the lack of an effect seen with silencing
Sp1 and Sp3was speciﬁc to N2a cells, Sp1, Sp3, and Sp4were each si-
lenced in cultured primary mouse cortical neurons. Gapdh served as
the internal control. Sp4 silencing resulted in a 64% decrease in its
mRNA levels (P b 0.01, Fig. 4G). Gria2's mRNA levels were also de-
creased signiﬁcantly by 61% (P b 0.05; Fig. 4H). However, Gria1, Gria3,
and Gria4 transcripts were not changed signiﬁcantly with Sp4 silencing
(Fig. 4H).
Silencing of Sp1 decreased its mRNA levels by 51% (P b 0.01, Fig. 4G)
and silencing of Sp3 decreased its mRNA levels by 57% (P b 0.01,
Fig. 4G). However, mRNA levels of Gria1–4 were not changed signiﬁ-
cantly by the silencing of either Sp1 or Sp3 (Fig. 4H).
3.8. Effect of over-expressing Sp1, Sp3, and Sp4 on AMPA receptor subunits
in N2a cells
To determinewhether over-expressing Sp1, Sp3, or Sp4 had an effect
on the expression of the AMPA receptor subunits, plasmids expressingSp1, Sp3, or Sp4were transfected into N2a cells. β-actin served as the in-
ternal control. Sp4 over-expression increased its mRNA levels ap-
proximately 30-fold (P b 0.001, Fig. 5A) and its protein levels by
132% (P b 0.01, Fig. 5C–D). The mRNA and protein levels of GluA2
were also increased by 135% and 47%, respectively (P b 0.001,
Fig. 5B and P b 0.05, Fig. 5E–F, respectively). On the other hand,
mRNA levels of Gria1, Gria3, and Gria4 did not change signiﬁcantly
with Sp4 over-expression (Fig. 5B), and neither did the protein
level of GluA1 (Fig. 5E–F), nor of GluA3 and GluA4 (Supplementary
Fig. 1C–D).
Sp1 over-expression led to a signiﬁcant 27-fold increase in its
mRNA levels (P b 0.001, Fig. 5A) and a signiﬁcant 63% increase in
its protein levels (P b 0.01, Fig. 5C–D). Sp3 over-expression led to a
signiﬁcant 39-fold increase in its mRNA levels (P b 0.001, Fig. 5A)
and a signiﬁcant 146% increase in its protein levels (P b 0.05,
Fig. 5C–D). However, mRNA levels of Gria1–4 (Fig. 5B) or protein levels
of GluA1 and GluA2 (Fig. 5E–F), or of GluA3 and GluA4 (Supplementary
Fig. 1C–D) did not change signiﬁcantly with over-expression of Sp1 or
Sp3.
3.9. Effect of over-expressing Sp1, Sp3, and Sp4 on AMPA receptor subunits
in primary neurons
Cultured mouse cortical neurons were transfected with Sp1, Sp3, or
Sp4 expression vectors to determine whether the lack of an effect seen
with over-expression of Sp1 and Sp3 was restricted to N2a cells. Gapdh
served as the internal control. Sp4 over-expression resulted in a
29-fold increase in its mRNA levels (P b 0.01, Fig. 5G). Gria2 mRNA
levels also increased signiﬁcantly by 131% with Sp4 over-expression
(P b 0.01; Fig. 5H). However, Gria1, Gria3, and Gria4 mRNA levels
were not changed signiﬁcantly (Fig. 5H).
Over-expression of Sp1 resulted in a signiﬁcant 63-fold increase in its
mRNA levels (P b 0.01, Fig. 5G) and over-expression of Sp3 resulted in
signiﬁcant 31-fold increase in its mRNA levels (P b 0.01, Fig. 5G). Gria2
mRNA levels increased signiﬁcantly with Sp1 and Sp3 over-expression
(P b 0.05 and P b 0.01, respectively; Fig. 5H), but those of Gria1, Gria3,
or Gria4 did not (Fig. 5H).
3.10. Silencing Sp4 abolished KCl-induced transcript up-regulation of Gria2
in N2a cells
Gria2 mRNA levels are up-regulated in response to neuronal
activity induced by physiological concentrations of KCl [15]. To
determine whether Sp1, Sp3, or Sp4 was necessary for this up-
regulation, control N2a cells and cells transfected with the respec-
tive shRNAs against these proteins were subjected to 20 mM KCl
for 5 h. While Gria2 transcript levels were signiﬁcantly increased
by 110% (P b 0.001) with KCl-induced depolarization, silencing of
only Sp4 abolished this increase (Fig. 6A). Silencing of Sp1 or Sp3
did not prevent the KCl-induced increase of Gria2 transcript
(Fig. 6A). KCl treatment increased transcript levels of Gria1, Gria3,
and Gria4 signiﬁcantly (P b 0.001; Fig. 6A), but levels of these sub-
units were not signiﬁcantly changed with silencing Sp1, Sp3, or Sp4
(Fig. 6A).
3.11. Over-expression of Sp4 rescued tetrodotoxin-induced transcript
reduction of Gria2 in N2a cells
Gria2 mRNA levels are known to be down-regulated in response
to a decrease in neuronal activity induced by the action potential
blocker TTX [15,29]. To determine if Sp factors could rescue the de-
crease in AMPA transcript levels induced by the TTX-mediated de-
crease in neuronal activity, control N2a cells and cells transfected
with Sp1, Sp3, or Sp4 over-expression vectors were subjected to
0.4 μM TTX-treatment for 3 days. TTX signiﬁcantly decreased Gria2
transcript levels by 44% (P b 0.01; Fig. 6B) but the decrease was
Fig. 4. Effect of silencing of Sp1, Sp3, or Sp4 on the expression of the AMPA receptor subunit genes using RNA interference. (A) N2a cells transfected with Sp1, Sp3, or Sp4 shRNA showed
signiﬁcant down-regulation of Sp1, Sp3, and Sp4 transcripts, respectively. N=6. (B) InN2a cells,Gria2 transcript levelsweredecreasedwith silencing of Sp4, but notwith silencing of either
Sp3or Sp1. N=6. (C–D) InN2a cells, protein levels of Sp1, Sp3, and Sp4 decreased signiﬁcantlywith shRNA against Sp1, Sp3, and Sp4, respectively. A representativewestern blot forβ-actin,
the loading control, is shown. N= 3. (E–F) Sp4 silencing reduced the protein levels of GluA2 but not that of GluA1. Protein levels of GluA1 and GluA2 did not change signiﬁcantlywith Sp1
or Sp3 silencing. The loading control was β-actin. N= 3. (G) shRNA against Sp1, Sp3, or Sp4 showed a signiﬁcant down-regulation in the transcript levels of Sp1, Sp3, and Sp4, respectively.
N =3. (H) Transcript levels ofGria2, but not Gria1,Gria3, andGria4, decreasedwith Sp4 shRNA in primary neurons. Transcript levels ofGria1-4 did not change signiﬁcantlywith Sp1 or Sp3
shRNA in primary neurons. N = 3. Pb0.05, Pb0.01, and Pb0.001 when compared to controls.
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alone; Fig. 6B). Gria1, Gria3, and Gria4 transcript levels decreased sig-
niﬁcantly with TTX treatment (P b 0.01, P b 0.001, and P b 0.001,respectively; Fig. 6B), but they were not rescued by Sp4 over-
expression (Fig. 6B). Over-expressing Sp1 or Sp3 could not rescue
the TTX-mediated decrease in Gria1–4 transcript levels (Fig. 6B).
Fig. 5. Effect of over-expressing Sp1, Sp3, or Sp4 on the transcript levels of AMPA receptor subunit genes. (A) N2a cells transfectedwith Sp1, Sp3, and Sp4 expression vectors revealed an up-
regulation of Sp1, Sp3, and Sp4 transcripts, respectively. N = 6. (B) Sp4 over-expression, but not Sp1 or Sp3 over-expression, increased Gria2 transcript levels. N = 6. (C–D) In N2a cells,
protein levels of Sp1, Sp3, and Sp4 were increased signiﬁcantly with over-expression of Sp1, Sp3, and Sp4, respectively. A representative blot of the loading control, β-actin, is shown.
N = 3. (E–F) In N2a cells, the protein level of GluA2, but not that of GluA1, was increased signiﬁcantly with over-expression of Sp4. Protein levels of GluA1 and GluA2 did not change sig-
niﬁcantly with over-expressing Sp1 or Sp3. The loading control was β-actin. N= 3. (G) Over-expression of Sp1, Sp3, or Sp4 in primary neurons increased transcript levels of Sp1, Sp3, and
Sp4, respectively. N=3. (H) Sp4, Sp3, and Sp1 over-expression increasedGria2 transcript levels, but notGria1, Gria3 and Gria4 transcript levels, in primary neurons. N=3. Pb0.05, Pb0.01,
and Pb0.001 when compared to controls.
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Fig. 6. Effect of changes in neuronal activity on Gria1, 2, 3, and 4 transcript levels in
the absence or presence of Sp1, Sp3, or Sp4 silencing or over-expression in N2a
cells. (A) Transcript levels of all AMPA receptor subunit genes were increased by
5 h of 20 mM KCl treatment. KCl is a depolarizing agent that increases neuronal
activity. Silencing Sp4 did not allow for transcript levels of Gria2 to increase with
KCl, but had no effect on the KCl-induced increase in the transcript levels of
Gria1, Gria3, and Gria4. Silencing Sp1 and Sp3 did not prevent the KCl-induced
up-regulation of Gria1–4 transcript levels. N= 6. (B) Transcript levels of all AMPA recep-
tor subunit genes were decreased with 3 days of 0.4 μM TTX treatment. TTX decreases neu-
ronal activity by blocking action potentials. Sp4 over-expression rescued the TTX-mediated
down-regulation of Gria2 transcript levels, but did not rescue the TTX-mediated down-
regulation of theGria1,Gria3, andGria4 transcripts. Sp1 or Sp3 over-expression could not res-
cue the TTX-mediated down-regulation ofGria1–4 transcript levels. N=6. *= P b 0.05, **=
P b 0.01, and *** = P b 0.001 when compared to controls. ### = P b 0.001 and X = non-
signiﬁcant when compared to KCl or TTX treatment alone.
Fig. 7. Effect of changes in neuronal activity on Gria1, 2, 3, and 4 transcript levels in the
absence or presence of Sp4 silencing or over-expression in rat visual cortical neurons.
(A) Transcript levels of Sp4 and all AMPA receptor subunit genes were increased by 5 h
of 20 mM KCl treatment. Silencing Sp4 reduced its own transcript levels as well as that
of Gria2, but not those of Gria1, 3, or 4. Sp4 silencing also did not allow for transcript levels
of Sp4 itself and Gria2 to increase with KCl, but it had no effect on KCl-induced up-
regulation of Gria1, Gria3, and Gria4 transcripts. N = 3. (B) Transcript levels of Sp4 and
all AMPA receptor subunit genes were decreased with 3 days of 0.4 μM TTX treatment.
Sp4 over-expression signiﬁcantly increased its own transcript levels as well as that of
Gria2, but not those of Gria1, 3, or 4. Sp4 over-expression also rescued the TTX-mediated
down-regulation of Gria2 transcript levels, but not those of Gria1, Gria3, and Gria4 tran-
scripts. N=3. *= P b 0.05, **= P b 0.01, and ***= P b 0.001when compared to controls.
#= P b 0.05, ##= P b 0.01, ###= P b 0.001 and X=non-signiﬁcantwhen compared to
KCl or TTX treatment alone.
Fig. 8. Aligned partial sequences of the Gria2 promoters from mice, rats, and humans
showed conserved Sp binding sites.
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in primary neurons
Transcript levels of Sp4, Gria1, Gria2, Gria3, and Gria4 in rat visual
cortical neurons were all signiﬁcantly up-regulated by 20 mM KCl for
5 h (P b 0.05–0.01; Fig. 7A). When neurons were transfected with Sp4
shRNA, transcript levels of Sp4 and Gria2 were signiﬁcantly down-
regulated to 44% and 45%, respectively (P b 0.01 and P b 0.05, respec-
tively), whereas those of Gria1, Gria3, and Gria4 were not affected
(Fig. 7A). Likewise, silencing Sp4 abolished the increase (Fig. 7A) in tran-
script levels of Sp4 and Gria2 induced by KCl depolarization (P b 0.01),
but did not affect those of Gria1, Gria3, and Gria4 (Fig. 7A).
3.13. Over-expression of Sp4 rescued tetrodotoxin-induced transcript
reduction of Gria2 in primary neurons
Transcript levels of Sp4, Gria1, Gria2, Gria3, and Gria4 in rat visual
cortical neurons were all signiﬁcantly down-regulated by 0.4 μM
TTX-treatment for 3 days (P b 0.05; Fig. 7B). Over-expressing Sp4 signif-
icantly up-regulated Sp4 and Gria2 transcripts by 163% and 237%,
respectively (P b 0.01 and P b 0.001, respectively), but did not affectthose of Gria1, Gria3, and Gria4 (Fig. 7B). Sp4 over-expression also
rescued Sp4 and Gria2 transcripts from being down-regulated by TTX
(P b 0.05 and P b 0.001, respectively, as compared to TTX alone), but
had no effect on those of Gria1, Gria3, and Gria4 (Fig. 7B).
3.14. Homology of the Sp binding site
The functional Gria2 Sp binding site is conserved among mice, rats,
and humans (Fig. 8).
4. Discussion
Using multiple molecular and biochemical approaches, including in
silico analysis, electrophoretic mobility shift and supershift assays,
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rodent primary cortical neurons, we document for theﬁrst time that it is
Sp4, and not Sp1 or Sp3, transcription factor that regulates the GluA2
(Gria2), and not GluA1 (Gria1), GluA3 (Gria3), or GluA4 (Gria4), subunit
of the AMPA receptor in neurons. Furthermore, a knockdown of Sp4
did not allow for the activity-mediated increase of Gria2, whereas
over-expression of Sp4 rescued the TTX-mediated down-regulations of
Gria2. The Sp binding motif on the Gria2 promoter is conserved among
mice, rats, and humans.
AMPA receptors are excitatory glutamatergic neurotransmitter re-
ceptors that mediate most of the excitatory neurotransmission in the
central nervous system (for review see [1]). These receptors are
heterotetrameric proteins composed of GluA1–4 subunits. Themajority
of AMPA receptors in the adult cortex and hippocampus contain the
GluA2 subunit in GluA1/GluA2 heterotetramers [2,7,8]. The expression
of GluA3 is lower than that of GluA1, and the GluA4 subunit is develop-
mentally expressed [7,8,11]. Our current study indicates that Sp4 regu-
lates only the GluA2 subunit of AMPA receptors.
Sp4 is in the speciﬁcity protein/Krüppel-like (SP/KLF) family of zinc
ﬁnger transcription factors that bind to GC-rich sequences of DNA (for
review see [17]). Of the 25 members in the SP/KLF family, Sp4 shares
critical amino acid homology in its DNA binding domainwith speciﬁcity
proteins 1 (Sp1) and 3 (Sp3), with all three factors competing for the
same cis-elements [17,18]. However, unlike Sp1 and Sp3, whose expres-
sion is ubiquitous, Sp4 is found primarily in the brain and testes [19,30].
Themurine brain has a greater abundance of Sp4 than either HeLa or
N2a cells, whereas the opposite is true for Sp1 and Sp3 [28]. Further-
more, in primary neurons, mRNA and protein levels of Sp4 are greater
than those of Sp1 [31]. In glial cells, however, Sp1 and Sp3 are the
major Sp factors present, with negligible expression of Sp4 [31]. Neuro-
nal expression of Sp4 increases with development and Sp4-null male
mice do not breed despite having a normal reproductive system, sug-
gesting that the deﬁcit lies in the nervous system [19]. Hypomorphic
Sp4mice have vacuolization in the hippocampal gray matter and deﬁ-
cits in both sensorimotor gating and contextual memory. Restoration
of Sp4 rescues all observable molecular, histological, and behavioral
abnormalities in these mice [32].
The Sp cis-motif was previously identiﬁed on the Gria2 promoter
[33], but consistentwith the importance of Sp4 in neurons is our ﬁnding
that it is Sp4, not Sp1 or Sp3, that regulates the expression of Gria2 in
neurons through this motif. Our results of a positive regulation of
Gria2 after over-expression of Sp1 and Sp3 in primary neurons may be
due to the absence of smaller isoforms of Sp1 and Sp3 in primary neu-
rons [28]. The smaller Sp3 isoforms are known to act as transcriptional
repressors and the same may be true for Sp1 [31]. Their absence in
primary neurons may allow over-expression of the exogenous full
length Sp3 or Sp1 to activate expression of target genes. N2a cells, on
the other hand, possess the smaller isoforms of Sp3 and Sp1 [28],
and so they did not exhibit positive regulation of Gria2 with an over-
expression of exogenous full length Sp3 or Sp1.
Of the four AMPA subunits, GluA1 to 4, it is remarkable that Sp4
regulates only GluA2. This subunit is quite unique, in that it undergoes
hydrolytic editing of its pre-mRNA in its transmembrane segment 2
from glutamine to arginine [9], thereby rendering GluA2-containing
AMPA receptors less permeable to Ca2+; and GluA2 homotetrameric
AMPA receptors are completely impermeable to Ca2+ [9,34,35]. Thus,
GluA2 subunit determines the functional properties of AMPA receptors,
including the I–V behavior of the channel and permeability to Ca2+
[36,37]. GluA2-containing AMPA receptors also exhibit low single chan-
nel conductance as compared to AMPA receptors that do not contain
GluA2 [37–40].
The special properties of the GluA2 subunit render it important for
normal neuronal activities, including synaptic plasticity, learning, and
memory (for reviews see [3,5]). GluA2 is involved in bidirectional
plasticity in the synapse as well as in AMPA receptor maintenance, in-
ternalization, and distance-dependent scaling [41–44]. Knocking downGluA2 blocks synaptic scaling [45]. GluA2 subunits are able to stimulate
synaptic function and promote the growth and formation of dendrit-
ic spines in cultured cortical neurons [43]. This is thought to be
through a direct interaction of GluA2's N-terminal domain with the
cell-adhesion molecule, N-cadherin [43]. A mechanism for the mainte-
nance of long-term potentiation (LTP), thought to underlie experience-
dependent plasticity, learning, and memory, can be through an increase
in GluA2-containing receptors in hippocampal synapses [46–48].
Knocking out Gria2 results in multiple behavioral abnormalities, includ-
ing deﬁcits in object exploration, grooming, eye-closure reﬂex, and spa-
tial and non-spatial learning [49]. Thus, by regulating GluA2, it is likely
that Sp4 plays an important role in mediating many of these neuronal
and synaptic processes.
The GluA2 subunit responds to changes in neuronal activity. Spe-
ciﬁcally, physiological concentrations of KCl, a depolarizing agent
that activates neuronal activity, increases both transcript and protein
expression of GluA2 in cultured visual cortical neurons [13]. On the
other hand, decreasing neuronal activity through TTX-induced impulse
blockade down-regulates GluA2 mRNA and protein levels in these neu-
rons [13]. Parallel to these neuronal activity-mediated changes is a
change in transcript and protein levels of cytochrome c oxidase (COX)
[13], a critical enzyme for energy generation in neurons [50]. In the
supragranular and infragranular layers of the macaque visual cortex,
GluA2 expression and COX activity levels are governed by visual input
and neuronal activity [12]. Speciﬁcally, monocular impulse blockade
induces a down-regulation of both GluA2 expression and COX activity
in deprived ocular dominance columns [12]. Thus, both GluA2 and
COX are tightly regulated at the cellular level by neuronal activity.
We have previously shown that Sp factorsmodulate COXmRNA and
protein levels in neurons [20]. Sp4, by regulatingGluA2 expression, cou-
ples neuronal activity and energy metabolism at the transcriptional
level. GluA2 expression is also controlled by nuclear respiratory factor
1 (NRF-1) [15], a transcription factor that regulates all 13 COX subunits
[16,22,29]. The present study indicates that Sp4 and NRF-1 employ the
concurrent and parallel mechanism to regulate the GluA2, but not
GluA1, GluA3, or GluA4 subunits.
A possible beneﬁt of the concurrent and parallel mechanism is that
the GluA2 subunit, important for AMPA receptor physiology and func-
tion, is regulated bymultiple transcription factors. However, it is unlike-
ly that these factors function redundantly. While both Sp4 and NRF-1
are positively regulated by neuronal activity [27,28,51], NRF-1 can inter-
act directly with an upstream coactivator, peroxisome proliferator-
activated receptor-γ coactivator 1α (PGC-1α), to induce target gene
expression [52,53], whereas Sp factors are not known to interact with
PGC-1α directly. However, Sp factors can interact with host cell factor
1 (HCF-1) [54], a co-activator that reportedly interacts with PGC-1α
[55], resulting in a possible indirect interaction between Sp factors and
PGC-1α in the induction of target gene expression. Sp factors are also
known to interact with a multitude of cellular proteins and undergo
numerous post-translational modiﬁcations [30,54]. Other contributing
factors, such as the cellular environment, cell signaling, and varying
amounts of neuronal activity may differentially recruit NRF-1 or Sp4
to regulate their common target genes, such as Gria2.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.02.008.
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